The Tongteng New Creation Process Development Laboratory covers an area of 200 square meters and has a professional process development team with a master's degree or above accounting for 60%. It is equipped with advanced cell culture, biochemical analysis, and storage equipment, and is guided by market demand for process development in the areas of stem cells, virus vaccines, and immune cell therapy.

Relying on the company's existing CEL-G ® Culture Ad60 Series fixed bed bioreactors and CEL-G ® TFF Lab A series of extracellular vesicle concentration systems have been developed in the process laboratory, including a complete extracellular vesicle culture and concentration platform, a high-yield virus production and recovery platform, and a 1 ㎡, 2 ㎡, 3.5 ㎡, 10 ㎡, 20 ㎡, and 60 ㎡ scale adherent cell culture and final product recovery platform.

Relying on the company's existing CEL-G ® Culture Ad600 A series of fixed bed bioreactors have been developed, and the process development laboratory has creatively developed a cell immobilization culture platform, which enables the amplification culture of 300 ㎡ and 600 ㎡ adherent cells, as well as the immobilization culture process of 300 ㎡ (equivalent 200L) and 600 ㎡ (equivalent 500L) suspended cells, providing new solutions and methods for suspension cell perfusion culture.